TAVR Hot Topics | Monday

Monday, March 11, 2024

1:30 PM – 5:55 PM ET

Program Director(s)

Kendra Grubb, MD

Surgical Director, Structural Heart and Valve Center
Emory University
Atlanta, Georgia, United States
Eberhard Grube, MD, FSCAI

Head CIIC
University Hospital Bonn
Siegburg, Nordrhein-Westfalen, Germany
Michael Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s):

Kendra J. Grubb, MD: No relationships to disclose

Presentations:

1:30 PM – 1:38 PM ET

Cerebral Protection: Why and How I Still Use it in 2024 – Review of the Available Data
Speaker: Robert Stoler, MD – Baylor Heart & Vascular Hospital Baylor University Medical Center
1:30 PM – 2:33 PM ET

CEREBRAL EMBOLIC PROTECTION DEVICES
Moderator: David J. Cohen, MD, FSCAI – Cardiovascular Research Foundation
Moderator: Samir R. Kapadia, MD, FSCAI – Cleveland Clinic
Moderator: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
1:38 PM – 1:46 PM ET

Update | The CAPTIS (Filterlex) and Emboline Full Arch and Beyond Embolic Protection
Speaker: Giora Weisz, MD – NewYork Presbyterian Hospital - Columbia University Medical Center
1:46 PM – 1:54 PM ET

Are Cerebral Embolic Protection Devices Needed for all Patients Undergoing TAVR?
Speaker: Richard J. Jabbour, MD – Southampton General Hospital
1:54 PM – 2:02 PM ET

Review of Available EPD Systems in Clinical Trials
Speaker: Samir R. Kapadia, MD, FSCAI – Cleveland Clinic
2:02 PM – 2:10 PM ET

Embolic Protection Devices in Challenging Anatomy
Speaker: James E. Harvey, III, MD – WellSpan Health
2:10 PM – 2:33 PM ET

Moderated Discussion: Embolic Protection for All TAVR Patients - The Pros and Cons
Panel Moderator: David J. Cohen, MD, FSCAI – Cardiovascular Research Foundation
Panel Moderator: Samir R. Kapadia, MD, FSCAI – Cleveland Clinic
Panel Moderator: Alexandra J. Lansky, MD, FACC, FAHA, FSCAI, FESC – Yale School of Medicine
Panel Discussant: James E. Harvey, III, MD – WellSpan Health
Panel Discussant: Issam Moussa, MD – Carle Health / University of Illinois Urbana Champaign
Panel Discussant: Giora Weisz, MD – NewYork Presbyterian Hospital - Columbia University Medical Center
2:33 PM – 2:41 PM ET

Why TAVR Fails
Speaker: Stephanie Sellers, PhD – University of British Columbia
2:33 PM – 4:15 PM ET

LIFETIME MANAGEMENT POST-TAVR AND VALVE IN VALVE
Moderator: Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital
Moderator: Stanley J. Chetcuti, MD – University of Michigan
Moderator: Isaac George, MD – New York Presbyterian - Columbia University Medical Center
Moderator: Kendra J. Grubb, MD – Emory University
2:41 PM – 2:49 PM ET

Strategies for Lifetime Management of AS: What Is Important to the Surgeons
Speaker: Isaac George, MD – New York Presbyterian - Columbia University Medical Center
2:49 PM – 2:57 PM ET

TAVR for the Young: Consensus and Controversy
Speaker: Harold L. Dauerman, MD – University of Vermont College of Medicine
2:57 PM – 3:05 PM ET

TAV-in-TAV Planning for the Second TAVR | The New App for Lifetime Management
Speaker: Vinayak Bapat, FRCS(CTh) – Abbott Northwestern Hospital & Minneapolis Heart Foundation
3:05 PM – 3:13 PM ET

Should the Possibility of Redo TAVR Influence the Choice and Technique of First TAVR?
Speaker: Neal S. Kleiman, MD, FACC, MSCAI – Houston Methodist DeBakey Heart and Vascular Center
3:13 PM – 3:21 PM ET

Making TAV-in-TAV Possible for All with Leaflet Modification Techniques
Speaker: Philippe Généreux, MD – Morristown Medical Center
3:21 PM – 3:29 PM ET

Lessons from the EXPLANT Registry
Speaker: Stephanie Sellers, PhD – University of British Columbia
3:29 PM – 3:37 PM ET

Patient-Prosthesis Mismatch: Rethinking Definition and Prognostic Implications
Speaker: Issam Moussa, MD – Carle Health / University of Illinois Urbana Champaign
3:37 PM – 3:45 PM ET

ShortCut for Prevention of Coronary Obstruction Post Valve-in-Valve: Global Experience
Speaker: Philippe Généreux, MD – Morristown Medical Center
3:45 PM – 3:53 PM ET

Coronary Revascularization Post-TAVR
Speaker: Stanley J. Chetcuti, MD – University of Michigan
3:53 PM – 4:15 PM ET

Panel Discussion: Lifetime Management of Patients and Valve-in-Valve with Severe AS
Panel Moderator: Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT – King Fahd Armed Forces Hospital
Panel Moderator: Stanley J. Chetcuti, MD – University of Michigan
Panel Moderator: Kendra J. Grubb, MD – Emory University
Panel Moderator: Isaac George, MD – New York Presbyterian - Columbia University Medical Center
Panel Discussant: Vinayak Bapat, FRCS(CTh) – Abbott Northwestern Hospital & Minneapolis Heart Foundation
Panel Discussant: Harold L. Dauerman, MD – University of Vermont College of Medicine
Panel Discussant: Philippe Généreux, MD – Morristown Medical Center
Panel Discussant: Neal S. Kleiman, MD, FACC, MSCAI – Houston Methodist DeBakey Heart and Vascular Center
Panel Discussant: Stephanie Sellers, PhD – University of British Columbia
Panel Discussant: Moritz C. Wyler von Ballmoos, MD, PhD, MPH – Texas Health Resources & TCU
4:15 PM – 4:23 PM ET

Bioprosthetic Valve Fracture: When and How?
Speaker: Mei Chau, MD – Montefiore Medical Center
4:15 PM – 5:55 PM ET

PRACTICAL AND HOT TOPICS
Moderator: Marvin Eng, MD – Banner University Medical Center
Moderator: Howard C. Herrmann, MD, FACC, MSCAI – Hospital of the University of Pennsylvania
Moderator: Robert J. Widmer, MD, PhD – Baylor Scott & White Health
4:23 PM – 4:31 PM ET

Peripheral Intervention to Facilitate Transfemoral TAVR in Patients with PAD: An Alternative to Alternative-Access TAVR
Speaker: Grant W. Reed, MD, MSc – Cleveland Clinic
4:43 PM – 4:55 PM ET

Valve-in-Valve with Balloon Valve Fracture
Speaker: Mei Chau, MD – Montefiore Medical Center
4:55 PM – 5:03 PM ET

Less than 10 Slides for A Less than 10% Pacemaker Rate - Best –in-Class Evolut
Speaker: Hemal Gada, MD – UPMC Central PA
5:03 PM – 5:11 PM ET

Should Patients with Asymptomatic AS Undergo TAVR?
Speaker: Philippe Généreux, MD – Morristown Medical Center
5:11 PM – 5:19 PM ET

Durability of Surgical and Transcatheter Valves: What Do We Know So Far?
Speaker: Stephanie Sellers, PhD – University of British Columbia
5:19 PM – 5:27 PM ET

Novel TAVR Devices: An Update on Valves for Aortic Regurgitation
Speaker: Eberhard Grube, MD, FSCAI – University Hospital Bonn
5:27 PM – 5:35 PM ET

Which Valve Type for Small Anatomies?
Speaker: Richard J. Jabbour, MD – Southampton General Hospital
5:35 PM – 5:43 PM ET

Moderate Aortic Stenosis
Speaker: Jeroen J. Bax, MD – Leiden University Medical Center
5:43 PM – 5:55 PM ET

Panel Discussion: Practical and Hot Topics
Panel Moderator: Marvin Eng, MD – Banner University Medical Center
Panel Moderator: Howard C. Herrmann, MD, FACC, MSCAI – Hospital of the University of Pennsylvania
Panel Moderator: Robert J. Widmer, MD, PhD – Baylor Scott & White Health
Panel Discussant: Jeroen J. Bax, MD – Leiden University Medical Center
Panel Discussant: Mei Chau, MD – Montefiore Medical Center
Panel Discussant: Hemal Gada, MD – UPMC Central PA
Panel Discussant: Philippe Généreux, MD – Morristown Medical Center
Panel Discussant: Grant W. Reed, MD, MSc – Cleveland Clinic
Panel Discussant: Jason Wasfy, MD – Massachusetts General Hospital
5:55 PM ET

Adjourn